Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04656535
Title AB154 Combined With AB122 for Recurrent Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yale University
Indications

glioblastoma

high grade glioma

Therapies

Zimberelimab

AB154

AB154 + Zimberelimab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.